HypoglycemiaHyperglycemiaBlood GlucoseInsulinPostoperative ComplicationsHypoglycemic AgentsDiabetes Mellitus, Type 1GlucoseGlucagonHyperinsulinismDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Hemoglobin A, GlycosylatedGlucose Clamp TechniqueTreatment OutcomeEpinephrineRetrospective StudiesBlood Glucose Self-MonitoringDiabetes MellitusTime FactorsInsulin Infusion SystemsPancreatic PolypeptideDiabetes ComplicationsInsulin, Long-ActingEpisode of CareC-PeptideGlucose Tolerance TestStreptozocinRisk FactorsInsulin ComaIntraoperative ComplicationsClinical AlarmsIslets of LangerhansProspective StudiesFollow-Up StudiesFastingGluconeogenesisDiabetic AngiopathiesVentromedial Hypothalamic NucleusSulfonylurea CompoundsHydrocortisonePostprandial PeriodNesidioblastosisInfant, NewbornInsulinomaCongenital HyperinsulinismPregnancy ComplicationsRecurrenceAcute DiseaseDiabetic KetoacidosisInsulin-Secreting CellsPancreas, ArtificialInsulin ResistanceGlipizideGlucokinasePregnancy in DiabeticsIncidenceCritical IllnessLiverRats, Sprague-DawleyDiabetic NeuropathiesNorepinephrineInfusions, IntravenousPregnancyPancreatectomyHomeostasisFatty Acids, NonesterifiedDiabetic NephropathiesDiazoxidePancreasGlucagon-Like Peptide 13-Hydroxybutyric AcidReference ValuesGlycosuriaInsulin LisproInsulin AntibodiesSeverity of Illness IndexMonitoring, AmbulatoryMetforminMonitoring, PhysiologicInsulin AspartInsulin, IsophaneBody WeightInfusions, SubcutaneousPhlorhizinDisease Models, AnimalDiabetic RetinopathyAwarenessDipeptidyl-Peptidase IV InhibitorsRats, WistarDiabetic ComaRisk AssessmentLength of StayCohort StudiesLactic AcidHuman Growth HormoneAutonomic Nervous SystemLactatesTomography, X-Ray ComputedBrain